Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Aminoalcohol beta3-adrenoceptor agonists and their use claimed by Fujisawa

Jan. 13, 2003

Sildenafil reported effective in preventing antidepressant-associated sexual dysfunction

Jan. 10, 2003

Successful conclusion of phase I trial of ZP-120

Jan. 10, 2003

NexMed completes dosing in two-year rat carcinogenicity study

Jan. 7, 2003

License agreement for Befar in South Korea

Dec. 30, 2002

Two pivotal phase III trials of Alprox-TD completed

Dec. 18, 2002

RenaZorb begins testing in animals

Dec. 12, 2002

European approval for Avodart for benign prostatic hyperplasia

Dec. 11, 2002

Lilly and Boehringer Ingelheim sign cocommercialization agreements for duloxetine

Dec. 10, 2002

Lilly Icos presents new PDE5 inhibitors for male and female sexual dysfunction

Dec. 9, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Fosun secures rights to Aribio’s AR-1001 in potential $4.7B deal
BioWorld
Shanghai Fosun Pharmaceutical (Group) Co. Ltd. is paying $60 million up front for an option to secure exclusive rights to Aribio Co. Ltd.’s oral phase III-stage...
Biogen AD drug shows tau, cognition benefit, despite trial miss
BioWorld
Biogen Inc. has decided to advance diranersen (BIIB-080) into registrational trials for early Alzheimer’s disease, even though the antisense oligonucleotide...